Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹8.81 Cr₹37 Cr₹51 Cr₹43 Cr₹29 Cr

What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?

The latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA is ₹8.81 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹8.81 Cr
Mar2025₹37 Cr
Mar2024₹51 Cr
Mar2023₹43 Cr
Mar2022₹29 Cr

How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹8.81 Cr
-76.36
Mar2025 ₹37 Cr
-27.20
Mar2024 ₹51 Cr
19.52
Mar2023 ₹43 Cr
46.71
Mar2022 ₹29 Cr -

Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹7,363.4 Cr 11.7% 52% 339% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹110,515.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -0.8% -0.5% -9.3% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

11.7%

52%

339%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses